BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38869672)

  • 1. A double plea for dyspnea as the next great cause of all ICU professions and for caution about the dyspnea-breathlessness equivalence.
    Demoule A; Decavèle M; Similowski T; Heunks L
    Intensive Care Med; 2024 Jun; ():. PubMed ID: 38869672
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioids for management of episodic breathlessness or dyspnea in patients with advanced disease.
    Cabezón-Gutiérrez L; Khosravi-Shahi P; Custodio-Cabello S; Muñiz-González F; Cano-Aguirre Mdel P; Alonso-Viteri S
    Support Care Cancer; 2016 Sep; 24(9):4045-55. PubMed ID: 27334130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breathlessness: different causes and qualities of dyspnea].
    Brack T
    Praxis (Bern 1994); 2009 Jun; 98(13):703-9. PubMed ID: 19551655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breathlessness Beliefs and Related Factors in Male Patients with Chronic Obstructive Pulmonary Disease.
    Bayraktar D; Felekoğlu E; Özgen Alpaydın A; Özalevli S
    Thorac Res Pract; 2023 May; 24(3):137-142. PubMed ID: 37503615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of breathlessness during spontaneous asthma and histamine-induced bronchoconstriction.
    Boudreau D; Styhler A; Gray-Donald K; Martin JG
    Clin Invest Med; 1995 Feb; 18(1):25-32. PubMed ID: 7768063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interdisciplinary management of chronic breathlessness.
    Reilly CC; Brighton LJ; Maddocks M
    Curr Opin Support Palliat Care; 2019 Sep; 13(3):193-199. PubMed ID: 31145134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial.
    Currow DC; Ekström M; Louw S; Hill J; Fazekas B; Clark K; Davidson PM; McDonald C; Sajkov D; McCaffrey N; Doogue M; Abernethy AP; Agar M
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30361250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study.
    Currow DC; Smith J; Davidson PM; Newton PJ; Agar MR; Abernethy AP
    J Pain Symptom Manage; 2010 Apr; 39(4):680-90. PubMed ID: 20413056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Dyspnea Exertion Scale of Breathlessness in People With Life-Limiting Illness.
    Sandberg J; Johnson MJ; Currow DC; Ekström M
    J Pain Symptom Manage; 2018 Sep; 56(3):430-435.e2. PubMed ID: 29753099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breathlessness services as a new model of support for patients with respiratory disease.
    Bausewein C; Schunk M; Schumacher P; Dittmer J; Bolzani A; Booth S
    Chron Respir Dis; 2018 Feb; 15(1):48-59. PubMed ID: 28718321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline.
    Charles MA; Reymond L; Israel F
    J Pain Symptom Manage; 2008 Jul; 36(1):29-38. PubMed ID: 18358689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictable adverse events such as respiratory depression highlight the need for caution when prescribing morphine for refractory breathlessness.
    Smallwood N; Politis J; Le B
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28889115
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioids, Exertion, and Dyspnea: A Review of the Evidence.
    Johnson MJ; Hui D; Currow DC
    Am J Hosp Palliat Care; 2016 Mar; 33(2):194-200. PubMed ID: 25294225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A community population survey of prevalence and severity of dyspnea in adults.
    Currow DC; Plummer JL; Crockett A; Abernethy AP
    J Pain Symptom Manage; 2009 Oct; 38(4):533-45. PubMed ID: 19822276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
    Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
    JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyspnea, Acute Respiratory Failure, Psychological Trauma, and Post-ICU Mental Health: A Caution and a Call for Research.
    Worsham CM; Banzett RB; Schwartzstein RM
    Chest; 2021 Feb; 159(2):749-756. PubMed ID: 33011205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Descriptors of breathlessness in Mexican Spanish].
    Vázquez-García JC; Balcázar-Cruz CA; Cervantes-Méndez G; Mejía-Alfaro R; Cossío-Alcántara J; Ramírez-Venegas A
    Arch Bronconeumol; 2006 May; 42(5):211-7. PubMed ID: 16740235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyspnea: diagnosis and management.
    Mahler DA
    Clin Chest Med; 1987 Jun; 8(2):215-30. PubMed ID: 3304812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.
    Barnes H; McDonald J; Smallwood N; Manser R
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011008. PubMed ID: 27030166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial.
    Galbraith S; Fagan P; Perkins P; Lynch A; Booth S
    J Pain Symptom Manage; 2010 May; 39(5):831-8. PubMed ID: 20471544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.